News & Events

Personalizing medicine: An introduction to pharmacogenomics

In this webinar, we will:

  • ● review the current approach to the field of medicine
  • ● discuss the details and depth of pharmacogenomics
  • ● explain the impact of pharmacogenomics on the field of medicine
  • ● explore the implementation of pharmacogenomics and the OneOme RightMed solution

May 24t…


Precision Medicine Event Features OneOme’s Director of Medical Affairs

Minnesota Health Care Roundtable Takes Place April 20th from 1-4 p.m.

MINNEAPOLIS (April 19, 2017) – Tomorrow, OneOme’s director of medical affairs Josiah Allen will join the Minnesota Health Care Roundtable on precision medicine. The panel, which includes local leaders in the field, takes place on Thursday, April 20, from 1 to 4 p.m. at the Downtown Minneapolis Hilto…


Results from OneOme’s RightMed test now can be integrated into a patient’s Electronic Medical Record (EMR)

MINNEAPOLIS (March 21, 2017) – OneOme continues to make strides to ensure its powerful pharmacogenomics testing is a lasting tool for patients and healthcare providers. Results from OneOme’s RightMed test, which analyzes an individual’s DNA to predict his or her response to medications, now can be i…


During Heart Month, OneOme Highlights How RightMed® Pharmacogenomic Test Can Help People Taking Heart Medications

RightMed Pharmacogenomic Test is a New Way for Your Physician to Improve the Effectiveness of Your Cardiovascular Prescriptions

MINNEAPOLIS (Feb. 1, 2017) – This Heart Month, people suffering from heart conditions have a new opportunity to improve the effectiveness of their cardiovascular treatments through their healthcare provider: OneOme’s RightMed pharmacogenomic test. The RightMed test uses the power of DNA to minimize…


Right the first time: How a Minneapolis company uses DNA tests to limit the side effects of psychiatric meds

MinnPost published an article recounting the story of how OneOme’s RightMed pharmacogenomic test helped identify an effective prescription treatment for a teenager struggling with mental health conditions.

For 10 years Carly and her family searched for the right medications and doses for her anxie…


OneOme’s Director of Medical Affairs to Speak on Power of Pharmacogenomics at Design of Medical Devices Conference

Josiah Allen Speaking at Emerging Technology Forum on April 13th at 10:15 a.m.

MINNEAPOLIS (April 10, 2017) – On Thursday, April 13, OneOme’s director of medical affairs Josiah Allen will speak about the power of pharmacogenomics in personalized medicine at the Design of Medical Devices Conference Emerging Technology Forum. The event, which explores “Personalized Medical Devic…


Cost-effectiveness of pharmacogenomics: Insights from real-world and modeling studies

This webinar will provide the background on cost-effectiveness analyses (CEAs), CEAs evaluating pharmacogenomic testing implementation using real-world data, background on models used in CEAs, and CEA studies using modeling or simulations evaluating pharmacogenomic testing in psychiatry, oncology, c…


OneOme Shares Findings of Pharmacogenomics Awareness Survey

RightMed test mitigates barriers for implementing pharmacogenomics

MINNEAPOLIS (March 27, 2017) – Pharmacogenomics company OneOme today announced the results of its clinician pharmacogenomic testing awareness survey. OneOme will formally share its findings at the Academy of Managed Care Pharmacy (AMCP) Managed Care & Specialty Pharmacy Annual Meeting, which begins…


How Personalized Medicine Will Make Us Healthier

Minnesota Monthly published an article describing how precision medicine can help improve people’s health, highlighting OneOme as a company that strives to bring precision medicine into routine clinical care.

The article cites the example of a woman who suddenly fell so ill that she was hours from…


OneOme Announces New Specimen Option to Further Bring Its Powerful Pharmacogenomic Test into Routine Clinical Care

MINNEAPOLIS (March 13, 2017) – OneOme today announced that healthcare providers now are able to order OneOme’s RightMed® pharmacogenomic test as part of an ordinary blood panel. Previously, the RightMed test was only available through a cheek swab. Making testing available using blood will further b…


The heart and pharmacogenomics: An introduction to pharmacogenomics in cardiology

In this webinar, you will learn:

  • an overview of pharmacogenomics as it applies to cardiology
  • the benefits, validity, and utility of PGx testing in cardiology
  • the features of the OneOme RightMed PGx test
  • the cardiology drugs covered by the test that have PGx implications and FDA guidelines

    Pharmacogenomics Company OneOme Announces Leadership Promotions

    Jason Ross will Serve as Chief Technology Officer, Josiah Allen Promoted to Director of Medical Affairs

    MINNEAPOLIS (Jan. 26, 2017) – Pharmacogenomics company OneOme announced today that Jason Ross will serve as its chief technology officer and that Josiah Allen was promoted to OneOme’s director of medical affairs.

    “We are glad to add Josiah Allen and Jason Ross to our leadership team,” said Paul Owe…


    Pharmacogenomics Company OneOme Announces Patent-Pending Status for RightMed® Test and RightMed Advisor

    MINNEAPOLIS (Jan. 10, 2017) – Pharmacogenomics company OneOme today announced the U.S. Patent and Trademark office has issued “Patent Pending” status for its RightMed pharmacogenomic test and RightMed Advisor, an online tool for providers to quickly and easily interpret test results and gain access…


    OneOme Receives Laboratory Clinical Certification from Five States

    Certification Reaffirms OneOme’s High Standards of Laboratory Quality

    MINNEAPOLIS (Jan. 9, 2017) – Twin Cities-based pharmacogenomics company OneOme announced today that it has earned laboratory certification in California, Florida, Maryland, Pennsylvania, and Rhode Island. These certifications affirm OneOme’s commitment to exceeding the specific clinical laboratory t…


    AAPA 2017

    OneOme will exhibit at the American Association of Physician Assistants Conference, May 15-19, 2017 in Las Vegas, NV. Visit us at booth #608.

    American Psychiatric Association's 2017 Annual Meeting

    OneOme will exhibit at the American Psychiatric Assocation’s 2017 Annual Meeting, May 20-24 at the San Diego Convention Center. Visit us at booth #1708.

    ASHP Summer 2017

    OneOme will exhibit at the American Society of Health-System Pharmacists Summer Meetings & Exhibition, June 3-7, 2017 in Minneapolis, MN. Visit us at booth #637.

    How your DNA has the potential to help you avoid the wrong medications

    How your DNA has the potential to help you avoid the wrong medications.
    Did you know more than half of the 4 billion prescriptions written in America this year will not work as intended (IMS, Trends Mol. Med. 2001)? It’s true, and the answer to why that’s the case lies in our DNA.


    American Association of Nurse Practitioners

    OneOme will exhibit at the American Association of Nurse Practitioners (AANP) national conference, June 20-25, 2017 in Philadelphia, PA.

    Ridgeview Announces Partnership with Twin Cities-Based OneOme, Provider of RightMed® Test

    Patients to Benefit from Personalized Prescription Treatment Options

    Waconia, Minn. (Dec. 5, 2016) – Driven to continually improve patient care, Ridgeview Medical Center today announced a partnership with Twin Cities-based pharmacogenomics company OneOme, developer of the RightMed test. Through this partnership, Ridgeview patients will have an opportunity to receive…


    Revolutionary Prescription Writing and Ordering Portal based on a Patient’s Genetic Profile allows Physicians to provide more Personalized Medications

    CEOCFO Magazine, a “weekly publication featuring in-depth interviews with many of today’s top corporate executives,” recently published an interview with Paul Owen, CEO of OneOme.

    In the interview Paul discusses the OneOme RightMed® pharmacogenomic test, an analysis of individual patients’ genetic…


    Pharmacy Executive Joins OneOme

    Harlan Langstraat, R.Ph., Will Assist in Business Development for Pharmacy-Related Partnerships

    MINNEAPOLIS (Nov. 30, 2016) – Pharmacogenomics company OneOme announced the addition of Harlan Langstraat, R.Ph., to its growing organization. Langstraat has joined OneOme to assist in business development activities.

    Langstraat’s career has included senior management positions in both for-profit…


    Minnesota Company Launches an Innovative Approach to Identifying Personalized Prescriptions

    OneOme Introduces the RightMed® Test to Personalize Medications, Based on Each Patient’s Own Genetic Makeup

    MINNEAPOLIS (Nov. 29, 2016) – A Minnesota company today announced it has launched an innovative physician-ordered test for identifying which medications may work best for individual patients. OneOme, a growing pharmacogenomics company, has introduced the RightMed test, making it possible for physici…


    OneOme Moves to Expand PGx Business Beyond Mayo Clinic With New PCR-Based Panel

    NEW YORK (GenomeWeb) – After more than a year building its business as a provider of pharmacogenomic data interpretation, PGx firm OneOme has now expanded with the launch of its own genetic test, a PCR-based panel covering 22 genes related to hundreds of drugs.

    Download full article


    Pharmacogenomics Company OneOme Achieves Key Milestones

    Twin Cities-based Company Sees Advancements in Financing, Lab Accreditation, Expanded Sales Team, Provider Partnerships, and EMR Integration

    MINNEAPOLIS (Nov. 14, 2016) – Pharmacogenomics company OneOme today announced it has reached several milestones in the start-up organization’s development. Among the key progress indicators are $4.75 million in financing, establishment of its Minneapolis laboratory and accreditation by the College o…


    Pharmacogenomics Company, OneOme, Receives CAP Accreditation

    MINNEAPOLIS (Oct. 31, 2016) – Twin Cities-based pharmacogenomics company OneOme announced today that the College of American Pathologists (CAP) has awarded accreditation to its Minneapolis, Minnesota, clinical laboratory based on the results of a recent on-site inspection.

    Considered the “gold sta…


    Pharmacogenomic Company, OneOme, To Present at 2016 Annual Meeting of the American Society of Human Genetics (ASHG)

    RightMed® Test and Interactive Results Make Prescriptions Personal

    MINNEAPOLIS (Oct. 1, 2016) – Twin Cities-based pharmacogenomics company OneOme will present at the 2016 Annual Meeting of the American Society of Human Genetics (ASHG) in Vancouver, British Columbia.

    Beginning with presentations on Oct. 19 and culminating in a workshop session on Oct. 20, OneOme’s…


    OneOme Named Finalist for 17th Annual Tekne Awards

    MHTA to Honor Minnesota’s Top Technology Companies and Individuals at the Nov. 16 Awards Ceremony

    MINNEAPOLIS (Oct. 3, 2016) – The Minnesota High Tech Association (MHTA) has named OneOme as a finalist in the Healthcare – Small and Growing category for the 2016 Tekne Awards, which will be held at the Minneapolis Convention Center on Wednesday, Nov. 16. The Tekne Awards honor Minnesota companies a…


    OneOme Adds Centra Health as Partner and Provider of RightMed Pharmacogenomic Test

    Patients at Centra’s Stroobants Cardiovascular Center will have access to a comprehensive, affordable pharmacogenomic test.

    MINNEAPOLIS (Sept. 29, 2016) – Driven to improve patient care and reduce overall healthcare costs, Twin Cities-based pharmacogenomics company OneOme continues to grow its global network and availability of the RightMed test with the announcement of a new partnership with Centra Health. Centra’s Stro…


    OneOme announces availability of RightMed pharmacogenomic test

    Comprehensive, affordable test can be ordered online by healthcare providers

    Minneapolis, Minn., July 19, 2016 – Driven to improve patient care and reduce overall healthcare costs, pharmacogenomics company OneOme announces the global availability of its RightMed test.

    The RightMed test is a cost-effective, comprehensive pharmacogenomic analysis of 22 genes provided as a part…


    Pharmacogenomics company OneOme moves steps closer to product launch

    Minneapolis company announces new chief executive, headquarters and lab

    Minneapolis, Minn., July 12, 2016 – In preparation for its full launch of the RightMed® pharmacogenomic test, OneOme announces Paul Owen as Chief Executive Officer and opens its new headquarters and lab in northeast Minneapolis. By mid-July, OneOme will make the RightMed test commercially available…


    Pharmacogenomics company OneOme achieves more key milestones

    Minneapolis company announces new leadership and first exhibition

    Minneapolis, Minn., June 20, 2016 – Pharmacogenomics company OneOme is pleased to announce key business milestones in advance of launching its RightMed test.

    The RightMed test is a cost-effective, comprehensive, personalized pharmacogenomic analysis of 22 genes provided at the point of care. The tes…


    OneOme expands leadership team in preparation for mid-year launch of its comprehensive pharmacogenomic test

    MINNEAPOLIS, March 17, 2016 /PRNewswire/ — OneOme, LLC, a pharmacogenomics company, announced today the hiring of Dr. Justin Odegaard, M.D., Ph.D. and Ross Higgins to manage and lead their pharmacogenomics testing laboratory. Both Dr. Odegaard and Mr. Higgins bring extensive background in laboratory…


    OneOme appears in Wall Street Journal

    The Wall Street Journal published an article explaining the benefits of pharmacogenomic testing. Pharmacogenomics identifies which inherited genetic variations a person has and predicts how an individual will — or will not — respond to specific medications. Because everyone responds to drugs differe…


    OneOme prepares for commercial launch in new state-of-the-art facility

    MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, announced today that it will move its corporate office and clinical laboratory to the Highlight Center in northeast Minneapolis in early 2016. The new location will expand OneOme’s operations with a high-throughput clinical laboratory…


    Introduction to psychiatric pharmacogenomics webinar

    OneOme presented a webinar on the use of pharmacogenomics in psychiatric medicine and the OneOme RightMed® pharmacogenomic test. Led by Josiah Allen, Medical Science Liaison of OneOme, the webinar will inform providers about:

    • ● the fundamentals of pharmacogenomic (PGx) testing
    • ● the clinical valid…


    OneOme Appoints Paul Owen as Chief Operating Officer

    MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, recently announced that it appointed Paul Owen as its Chief Operating Officer.

    Troy Kopischke, CEO, stated: “Owen’s experience and expertise in pharmacogenomics are incredible assets for OneOme. His leadership will drive OneOme toward…


    OneOme analyzes first genetic data from Mayo Clinic patients, delivers first reports

    MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, recently analyzed genetic data from the first two patients using the PGxExpress product developed in collaboration with Mayo Clinic. Both analyses were delivered successfully in the form of comprehensive reports to the patients through…